RCAG
GH icon

Rehmann Capital Advisory Group’s Guardant Health GH Stock Holding History

Rehmann Capital Advisory Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$191 Buy
+3
New +$264 ﹤0.01% 1656

Other funds holding GH

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Rehmann Capital Advisory Group's GH Position: Q3 2019 in Review

Rehmann Capital Advisory Group opened a new position in Guardant Health (GH) in Q3 2019: 3 shares worth $191. The stake represents ﹤0.01% of the portfolio and ranks #1656 among its holdings.

242 funds tracked by Wall St. Rank hold GH as of Q3 2019.

  • Rehmann Capital Advisory Group held 3 shares of Guardant Health worth $191 as of Q3 2019.
  • Guardant Health was a new Rehmann Capital Advisory Group position in Q3 2019.
  • Guardant Health made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1656 holding.
  • 242 funds tracked by Wall St. Rank held Guardant Health as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.